InvestorsHub Logo
Followers 22
Posts 2285
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Sunday, 08/25/2013 7:04:09 PM

Sunday, August 25, 2013 7:04:09 PM

Post# of 442
NEW YORK — Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and add to its pipeline of new drugs.

Amgen Inc. said Sunday it will acquire Onyx for $125 per share, and it expects to complete the deal at the beginning of the fourth quarter. The companies value the deal at $9.7 billion excluding Onyx's cash, and Amgen said it will use $8.1 billion in committed bank loans to finance the deal.
http://www.idahostatesman.com/2013/08/25/2725110/amgen-may-buy-cancer-drug-maker.html#storylink=cpy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMGN News